SEC Form 4 · accession 0001628280-26-060234
Camp4 Therapeutics Corp · CAMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kelly Gold
Officer — Chief Financial Officer
Period of report
Aug 31, 2026
Accepted (ET)
Sep 2, 2026 · 7:50 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001736730
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 31, 2026 | P | 10,000 | $3.96 | A | 10,000 | I | By Spouse |
| Common StockF3 | holding | — | — | — | 76,467 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares reported herein were purchased in the open market in multiple transactions at prices ranging from $3.88 to $4.00, inclusive. The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to CAMP4 Therapeutics Corporation, any security holder of CAMP4, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- F2The shares reported herein are held in a brokerage account in the name of David Gold, the Reporting Person's spouse. The Reporting Person does not exercise investment control over this account. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose.
- F3Includes 2,039 shares previously acquired by the reporting person pursuant to the CAMP4 Therapeutics Corporation Employee Stock Purchase Plan (the "ESPP") in a transaction that was exempt under Rule 16b-3(c).